Glucocorticoid-induced osteoporosis: an update

J Compston - Endocrine, 2018 - Springer
Glucocorticoid-induced osteoporosis is the most common secondary cause of osteoporosis
and the resulting fractures cause significant morbidity. Following initiation of oral …

Management of endocrine disease: secondary osteoporosis: pathophysiology and management

F Mirza, E Canalis - European journal of endocrinology, 2015 - academic.oup.com
Osteoporosis is a skeletal disorder characterized by decreased mass and compromised
bone strength predisposing to an increased risk of fractures. Although idiopathic …

Treatment of low bone density or osteoporosis to prevent fractures in men and women: a clinical practice guideline update from the American College of Physicians

A Qaseem, MA Forciea, RM McLean… - Annals of internal …, 2017 - acpjournals.org
Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women: A
Clinical Practice Guideline Update From the American College of Physicians | Annals of Internal …

Vitamin D supplementation for prevention of mortality in adults

G Bjelakovic, LL Gluud, D Nikolova… - Cochrane database …, 2014 - cochranelibrary.com
Background Available evidence on the effects of vitamin D on mortality has been
inconclusive. In a recent systematic review, we found evidence that vitamin D 3 may …

Glucocorticoid-induced osteoporosis

K Briot, C Roux - RMD open, 2015 - rmdopen.bmj.com
Corticosteroid-induced osteoporosis is the most common form of secondary osteoporosis
and the first cause in young people. Bone loss and increased rate of fractures occur early …

American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid‐induced osteoporosis

JM Grossman, R Gordon, VK Ranganath… - Arthritis care & …, 2010 - Wiley Online Library
Although glucocorticoids may effectively be used in the management of many inflammatory
conditions, their use is associated with significant morbidity and mortality. Osteoporosis, with …

EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical …

GK Bertsias, JPA Ioannidis, J Boletis… - Annals of the …, 2008 - ard.bmj.com
Objective: Systemic lupus erythematosus (SLE) is a complex disease with variable
presentations, course and prognosis. We sought to develop evidence-based …

Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis

KG Saag, R Emkey, TJ Schnitzer… - … England Journal of …, 1998 - Mass Medical Soc
Background Osteoporosis is a common complication of long-term glucocorticoid therapy for
which there is no well-proved preventive or restorative treatment. Methods We carried out …

Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease

EM Scott, I Gaywood, BB Scott - Gut, 2000 - gut.bmj.com
Osteoporotic fractures are a major public health problem. It has been estimated that in the
USA the remaining lifetime fracture risk at the age of 50 years is 40% for white women and …

Vitamin D and bone health; Potential mechanisms

E Laird, M Ward, E McSorley, JJ Strain, J Wallace - Nutrients, 2010 - mdpi.com
Osteoporosis is associated with increased morbidity, mortality and significant economic and
health costs. Vitamin D is a secosteriod hormone essential for calcium absorption and bone …